Evidence map›Paper›PMID 24350243›Full record

ReviewBioMed research international2013

Topical promethazine side effects: our experience and review of the literature.

C Cantisani, S Ricci, T Grieco, G Paolino, V Faina, E Silvestri, S Calvieri

Open access · hybridAbstract readReview
In one paragraph

Review in BioMed research international, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. The epidemiology and phenomenology of non-antipsychotic-induced dystonia: a hybrid systematic-narrative review.European psychiatry : the journal of the Association of European Psychiatrists · 2025
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Role of G-protein coupled receptors in cardiovascular diseases.Frontiers in cardiovascular medicine · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Promethazine exhibits antiparasitic propertiesAntimicrobial agents and chemotherapy · 2019
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

C CantisaniDepartment of Dermatology and Plastic Surgery, University "Sapienza" of Rome, Viale del Policlinico 155, 00161 Rome, Italy.
S RicciSection of Legal Medicine, Department of Anatomical, Histological, Medical Legal and Locomotive System Sciences, University of Rome "Sapienza", Viale Regina Elena 336, 00161 Rome, Italy.
T GriecoDepartment of Dermatology and Plastic Surgery, University "Sapienza" of Rome, Viale del Policlinico 155, 00161 Rome, Italy.
G PaolinoDepartment of Dermatology and Plastic Surgery, University "Sapienza" of Rome, Viale del Policlinico 155, 00161 Rome, Italy.
V FainaDepartment of Dermatology and Plastic Surgery, University "Sapienza" of Rome, Viale del Policlinico 155, 00161 Rome, Italy.
E SilvestriDepartment of Dermatology and Plastic Surgery, University "Sapienza" of Rome, Viale del Policlinico 155, 00161 Rome, Italy.
S CalvieriDepartment of Dermatology and Plastic Surgery, University "Sapienza" of Rome, Viale del Policlinico 155, 00161 Rome, Italy.
Policlinico Umberto I · ITSapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Promethazine hydrochloride is a first-generation H1 receptor antagonist, antihistamine, and antiemetic medication that can also have strong sedative effects. The apparent ability of topical H1r/2r antagonists to target epidermal H1/2r was translated into increased efficacy in the treatment of inflammatory dermatoses, likely due to decreased inflammation and enhanced barrier function.

Indexed as

EpidermisHistamine H1 AntagonistsHumansInflammationPromethazineSkin DiseasesHistamine H1 AntagonistsPromethazine

Identifiers

PMID24350243
PMCPMC3852816
OpenAlexW2046270377

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.